Total operating revenues were $1.2 billion for the three months ended June 30, up from $1.1 billion posted over the same period last year, according to its finance report released Aug. 21. Patient service revenues were $982.5 million for the quarter, up from $797.7 over the same period in 2023.
Operating expenses totaled $1.15 billion for the quarter, up from $1.1 billion over the period in 2023. Wage and benefit costs were $483.6 million, up from $456.1 million, Supply costs were $212.7 million, up from $197.6 million.
Days of cash on hand was 360.4 as of June 30, up from 307.1 on Sept. 30.
Scripps posted a net income of $134.4 million in the third quarter up from $90.9 million in the same quarter last year.
For the nine months ended June 30, Sripps posted an operating income of $168.2 million, up from a $53.1 million loss over the same period last year.
Scripps said the increase in operating income was attributable to an 8.3% increase in hospital volumes and a $62.2 million increase in net reimbursement from the Provider Fee Program. The program charges hospitals a quality assurance fee that is used to obtain federal matching funds for Medi-Cal with the proceeds redistributed as supplemental payments to California hospitals that treat Medi-Cal patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
